Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer

BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated the efficacy and safety of irinotecan, 5-FU and a low dose of LV (modified FOLFIRI)...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Lee, Myung-Ah, Byun, Jae-Ho, Shim, Byoung-Young, Woo, In-Sook, Kang, Jin-Hyung, Hong, Young Seon, Lee, Kyung Shik, Choi, Myung Gyu, Chang, Suk Kyun, Oh, Seong Taek, Choi, Sung Il, Lee, Doo Suk
التنسيق: Artigo
اللغة:Inglês
منشور في: The Korean Association of Internal Medicine 2005
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891154/
https://ncbi.nlm.nih.gov/pubmed/16295778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2005.20.3.205
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة